GKB Ophthalmics Ltd Share Price Today - GKB Ophthalmics Ltd Stock Price Live NSE/BSE

GKB Ophthalmics Ltd

NSE: GKB BSE: 533212

₹58.86

(-3.67%)

Tue, 10 Mar 2026, 00:30 pm

MTF 5xInvest in GKB Ophthalmics Ltd with 5x Leverage Buy with MTF

Market Cap296.69M

PE Ratio0

Dividend0

Health Technology

Medical Specialties

24.5K

GKB Ophthalmics Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
26.83
Net Profit
-7.08
P/B
0.58
Sector P/E
48.36
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.28
Interest Cover (Industry)
3.41
ROCE (Industry)
4.65
RONW (Industry)
3.02
ROE
-12.66
ROCE
-6.05
Debt/Equity
0.23
EPS (TTM)
0
Dividend Yield
0
Book Value
104.27
Interest Cover
-1.84

Analysis

all

Pros

GKB Ophthalmics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
GKB Ophthalmics has been profitable on average in the past, therefore cash runway is not a concern.
GKB Ophthalmics has been profitable on average in the past, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 4.3x debt.
GKB Ophthalmics's cash and other short term assets cover its long term commitments.

Cons

Unable to calculate sustainability of dividends as GKB Ophthalmics has not reported any payouts.
Unable to evaluate GKB Ophthalmics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate GKB Ophthalmics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Debt is not well covered by operating cash flow (14.6%, less than 20% of total debt).
The level of debt compared to net worth has increased over the past 5 years (24.4% vs 28.5% today).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	51.13	51.06	51.06	50.99	50.98
FII	1.79	1.79	1.79	1.79	1.79
DII	0	0	0	0	0
Public	47.09	47.16	47.16	47.23	47.23
Government	0	0	0	0	0

Technical Analysis

RSI

53.15

MACD

0.18

50 DMA

55.40

200 DMA

65.86

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	107.70	84.65	71.76	61.60	48.71	38.55	15.50
Fibonacci	84.65	75.85	70.41	61.60	52.80	47.36	38.55
Camarilla	65.20	63.09	60.97	61.60	56.75	54.63	52.52

Pivots Level: Classic

+46.10

107.70

+23.05

84.65

+10.15

71.76

61.60

Pivot Point

LTP: 59.09

-12.90

48.71

-23.05

38.55

-46.10

15.50

Moving Average

SMAEMA

Period

Value

10-EMA
57.54
20-EMA
57.73
30-EMA
57.35
50-EMA
57.03
100-EMA
58.92
200-EMA
64.93

Announcement Date	Purpose	Action	Ex Date
12 Feb 2026	board-meetings	Quarterly Results
14 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
30 May 2025	agm
05 Jun 2024	agm
30 May 2023	agm
30 May 2022	agm
10 Jun 2021	agm
26 Jul 2014	agm	Annual General Meeting	28 Aug 2014
21 Jul 2013	agm	Annual General Meeting	23 Aug 2013
02 Jul 2012	agm	30th Annual General Meeting	06 Aug 2012

GKB Ophthalmics Ltd

Varun Beverages Ltd

Hindustan Unilever Ltd

Godrej Consumer Products Ltd

Britannia Industries Ltd

Nestle India Ltd

GKB Ophthalmics Ltd About

GKB Ophthalmics is engaged in manufacture and sale of ophthalmic lenses made up of Glass and Plastic.

Industry

Personal Care - Indian

Founded

1981

Headquarters

CEO

K G Gupta

Employees

Contact

Website

http://www.gkb.net

investor.grievance@gkb.net

Phone

91-832-2257253/6714444

Location

16-A, Tivim Industrial Estate, Mapusa, Goa, 403526

Year	History
2000	The company declared a 12% interim dividend.
2003	Rodenstock allied with GKB to manufacture lenses.
2008	GKB Ophthalmics Ltd inked an alliance agreement with Spain-based multinational company Indo to market high-end optical and ophthalmic products.
2010	GKB Ophthalmics got its shares listed on the Exchange in the list of 'B' Group Securities. The company designated an E-mail Id for investor complaints.
2011	GKB Ophthalmics Ltd appointed Mr. Joseph A.A. Dcosta as an additional Non Executive Independent Director.

Client Name	Order Side	QTY	Avg Price	Date
BRIJENDRA KUMAR GUPTA	Sell	37625	103.68	10 Dec 2024
COUNTER CYCLICAL INVESTMENTS PRIVATE LIMITED	Sell	79754	136.4	29 Apr 2024
RAGINI CHETAN MEHTA	Sell	818	132.75	29 Apr 2024
RAGINI CHETAN MEHTA	Buy	27869	135.89	29 Apr 2024
AMIT KUMAR JAIN HUF	Buy	17056	120.26	23 Apr 2024
AMIT KUMAR JAIN HUF	Sell	27056	117.38	23 Apr 2024
SANJIV KUMAR GUPTA	Sell	28121	113.99	10 Apr 2023
AGARWAL KUMAR RAJ	Sell	29874	173.7	24 Jan 2023
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED	Buy	33419	103.63	28 Dec 2022
AGARWAL KUMAR RAJ	Sell	29000	103.85	28 Dec 2022

GKB Ophthalmics Ltd News

GKB Ophthalmics Q3FY26 Results Show Mixed Performance

GKB Ophthalmics reported Q3FY26 standalone profit of ₹98.08 lakhs vs loss of ₹16.74 lakhs in Q3FY25, while consolidated profit reached ₹70.72 lakhs. Revenue declined but subsidiary liquidation proceeds boosted performance.

12 Feb 2026

co actions results

GKB Ophthalmics Insider Trading Disclosure Filed

Krishna Gopal Gupta & Sons HUF purchased 3,607 equity shares worth ₹2.14 lakh in GKB Ophthalmics between November 20 and December 10, 2025, as disclosed under SEBI insider trading regulations.

30 Dec 2025

stocks

GKB Ophthalmics Shareholders Approve Voluntary Winding Up of Material Subsidiary GSV Ophthalmics

GKB Ophthalmics Limited shareholders passed resolutions through postal ballot on November 1, 2025, approving the voluntary winding up of material subsidiary GSV Ophthalmics Private Limited and related party transactions worth Rs. 15 crores. The subsidiary, which holds the company's Rs. 11.70 crores investment, never commenced operations since inception due to COVID-19 disruptions making the project financially unviable, with proceeds to be used for general corporate purposes.

26 Nov 2025

corporate action

GKB Ophthalmics' Material Subsidiary GSV Ophthalmics Approves Voluntary Liquidation

GSV Ophthalmics Private Limited, a material subsidiary of GKB Ophthalmics Ltd., has approved voluntary liquidation under the Insolvency and Bankruptcy Code through a special resolution passed at an extraordinary general meeting. The subsidiary has appointed Manoj G. Nair as the liquidator to carry out the voluntary liquidation process, following earlier approvals from the subsidiary's board and the holding company's shareholders.

21 Nov 2025

corporate action

GKB Ophthalmics Reports Consolidated Profit of Rs 58.21 Lakhs Despite Standalone Loss in H1 FY2026

GKB Ophthalmics Limited posted a consolidated profit of Rs 58.21 lakhs for the half-year ended September 30, 2025, while reporting a standalone loss of Rs 266.72 lakhs for the same period. The company's Board approved voluntary winding up of its material subsidiary GSV Ophthalmics Private Limited, which was not carrying any business since inception.

14 Nov 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800